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Objectircs This study was conducted to dttmndue whether the 
ocdusion-mpafuatoa model OF myerardij tsebemtu. 
Barkgrouud. Omega-3 futty acids found tu &b 00 bavt varbnu 
bttdugtc prupertlm that may ntedtfy mywurdiat tnjury reused by 
were &hernia and rep~rfuskm. 
Methods. Of 21 dug8 fed an Mm&al dtet, 10 were g&n 
supplcmrnW Rsb en cenmtuing 0.06 g&g per &y ut etwapcn- 
beuutc uctd for 6 webs. Under auestbrstu aud opo chest 
ceudbiuus, the tett ctrcumtkx eerenary artery was ecctudcd fur 
90 min. followed by 6 h oFnperfusltm. Regteaal myeavdht bbud 
Row wus mewwed with 15pm spheres before and durtng arclu- 
slnn and durin9 reperfusiun. The area at risk and infarct she were 
measured using standard statnbtg techntmtes. 
Rrsuffs. IO the doga recetving &tppkm&at tTab dt, the ptatekt 
cd membrane eoutent et ~icer.uc~~& urtd tncreakd hvm 
Epidemiologic studies (1,2) indicate that death from cardio- 
vascular disease is inversely related to the amount of marine 
food products consumed. This beneficial effect of seafood 
has been related to its high content oiomega-3 polyunsatu- 
rated fatly acids. These fatty acids have significant biologic 
etkts, including alteration in eicosanoid production (14) 
and effects on urotein synthesis (5.61, enzyme activitv (7) 
and receptor ftktion (gj. 
In humans, diets with a high fish oil content modify 
several risk factors of atherosclerosis. Dietarv fish oil sun- 
plementation has favorable effects on hyperlipidemia (9) and 
lowers blood prersure in hypertensive patients (IO). Fish oil 
diets also decrease platelet aggregation (11.12) and modify 
inflammatory cell function (5.13-15). In animal medelr. 
dietary supplementation with fish oil has been shown to 
retard development of atherosclerosis (16.17). Recent stud- 
0.9 i 0.66% te7.1* 4.0% tp < 0.001). Marct3brms 29 * 7% 
inlheeonlralgmup~l3*3%~~~~~p(p<O.~l. 
There et18 au Srgutkaut dtUereuee ia the myerardmt area ut rtsh 
er RtCQrrssure pruduct bm*een the eeutmt aud mb eu gruups. 
There wm M dt&mtce la re&uuJ q yerardtat btwd tluvr k- 
tweentbegruupratbmetbte@tudyerdartugcereum9ecctasio. 
aud rrputusbu. 
couclwiuar, nmaq mb oil suppkmatatieu a@dtkautty re. 
ducedmyuwdYtu9arctsizetathtsmwkt.ThedtFeremuiu 
blfaretshedtdnatappmrtekretated*dMiudMtksb 
reghwulm~bkd3ewer~efuu9gmmu- 
umlptMt.Fu~~-UgaUeatSaeCdCd(o-theMhl~ 
uftheprdeeuvettwMakm u9emega-3fatt9actdstmmymerdtuJ 
btfarct &e. 
(3 Am cdl cur&t 1~3:21:19&9-5) 
ies (l&19) in humans suggest that the rate of nstenosis after 
coronary angiofdasty may be reduced. 
In animal models, dietary supplementation with fish oil 
has been shown to atTect myocardial infarct size. Gulp et al. 
(20) demonstrated a reduction in myocardial infarct size after 
coronary artery occlusion in dogs given supplemental 6 
etarv fish ail. and Hock et al. 1211 remrtcd a reduced infarct 
sizeafler coronary occlusion in a raimodel. In both oft&e 
studies. the investigators used a model of permanent cow 
nary occlusion. However, no information is available on 
whether dietary fish oil supplementation alters the extent of 
myucardial necrosis induced by severe ischcmia followed by 
rep&&m. 
ARer coronary lhrombotic occlusion, repelfusion of isch- 
emit myocardium occurs frequently, either spontaneously 
or as a result of therapeutic intervention. Although the net 
effect of early reperfusion is believed to decrease myocardiai 
damage. several investigators (22) believe that repxtusion 
may also have deleterious effects. It has been proposed (22) 
that invasion of inflammatory cells into ischemtc myocar- 
dium and the formation of oxygen free radicals during 
reprfusion may promote cell death in otherwise viable 
myocardium and thus atfect final infarct size. 
The putpose of the present study was to determine 
whether dietary omega-3 fatty acid supplementation wotdd 
reduce myocardial infarct size in a canine model of myocar- 
dial ischemia followed by repetfusion. We supplemented the were xcowed by centrifugation at 1,858 g for 20 mitt at 
diet of IO mongrel dogs with a defined content of eicosapen- 4°C. The wet platelet pellet was homogenized in a glass 
laenoic acid (20~5 omega-3) and ocosahexaenoic acid (22% tissue winder with 2.5 ml of chlorofolminleihanol I:i 
omega-3) for 6 weeks. These animals and I I contml dogs 
underwent open chest coronary occlusion for !%I min fol- 
lowed by 6 h of reperfusion. 
Methods 
Feeding protoml. Ten male or female mongre! dog? with 
an average weight of 15.7 kg received supplementnl Mufax- 
EPA fish-oil for%6 weeks. The dosage was-O& g/kg per day 
of eicosaoentaenoic acid (20:s omeaa-3) and 0.04 e/ka cer 
day ofd&osahexaenoic acid (22% o&a-3). The &o&i of 
fish oil giwt was adjusted according to weigh: Avery 2 
weeks. The oil was mixed with 0.5 oz :I4 g) of canned dog 
food given once a day. Otherwise. the dogs had free access 
lo unsupplemented food. As a control group, I2 dogs of 
comparable weight were fed the same diet without fish oil 
supplementation. Five dogs in the control group remained on 
their diet for 6 weeks before the experiment for better 
mmparison with the fish oil group. The other seven dogs 
remained on their diet for 1 to 2 weeks before the exrwiment 
was performed. There was no signiilcant d&r& in body 
weight between the two groups. All animals used in this 
study were maintained according lo a protocol approved by 
Loyokis Institutional Animal Care and Use Committee. 
SampI@ dprlpheral Moo& Basetine blti samples for 
assesstnent of platelet aggregation, platelet membrane fatty 
acid analysis and whole blood viscosity were drawn within 2 
days of arrivd to our animal cafe facility. The second set of 
samples for comparison studies was drawn within 2 days of 
the experiment. Blood was drawn into plastic syringes 
through an IS-gauge needle from a superiicial foreleg vein. 
IWekt a8qe@w. Nine milliliters of whole blood was 
drawn into I ml of O.IEmoffliter sodium citrate. The con- 
centration of sodium citrate can afleet both plalelet yield and 
platelet aggregation in dogs (23). &spite the lower yield OF 
platelets. we obtained better and more consistent aggroga- 
tion rewonsea with O.l2~mol!liter sodium citrate. F’kdelet- 
rich &ma was prepared by centrifugatian at I50 g for 
I5 mitt at 24°C. Platelets were counled in an automated cell 
counter (model S plus 4, CoulW. Aggregation studies were 
perforated within 2.5 h of phlebotomy in a platelet aggrega- 
(ion profiler (model-PAP-4, BlOiDATA Corporation). Plate- 
let agonists were collagen (0.8 &ml) and adenosine diphos- 
phate (ADP, I2 pmoliliter). These agents give reproducible 
aggregation responses in dogs (23). The resp~twe to ADP 
was monitored for 3 to 5 mht and the response to collagen for 
10 to I5 min. 
(volumeivolume). The homogenate was traosferred to a 
fritted disk glass funnel and rinsed with I8 ml ofchloroform/ 
methanol (I: I), and IO ml ofchloroform was added to adiusr 
the final solvent ratio to 2~1. The extract was dried uidor 
nitrogen gas. To remove water-soluble contaminants, 4 ml of 
chlorofo~lmetbattol (2~1) was added to ihe dtied oxtirit, 
followed by the addition of a G.8 ml of 0.05 mobliter 
pc:assium chloride. This mixture was txixed by vortex for 
IO s, then allowed to phase. The lower chlomforto layer was 
removed and dried and stored under nitrogen gas at -ZW 
until analyzed. Fatty acids were determined in the platelet 
lipid extnct by gas chromatography. The lipid extracts were 
suspended to petroleum ether and subjected to Wattsestetifi- 
cation by boron Wluoride methanol. This method is s& for 
unsaturated fatty acids and complete for methylation of free 
and estctitied fatty acids (24). The methyl esters of the fatty 
acids were analyzed by gas chromatogtapby on a Varian 
model 5703 chromatogmph W&an Instrments) fitted with 
a 4.mm internal diameter column packed with Silas-1Dc on 
GCOII. 100-200 mesh (Alltech). The analysis wascarried out 
with-a variable tern&awe program at 180” to 2WC at 
I%nio x ?O min. Nitrogen canierga;wasused at40 mUmin. 
This oroanm setwates arachidonate (20:4) from eicosavan- 
taettdic &id (20%). Fatty acids are q~ti8ed by peak k 
determination using identiceJ standtorts forcampatison. Pen- 
tadecaenoic acid (15~0) was used as an internal standard. 
ExprimenM proto&. A model of open chest atwho- 
tized doas was used. ARer atteslhesia with aloha&oralase 
(75 m&g intravenously) and surgical instt&entation as 
described previously (25). the dogs were stabtired for 
a20 mitt before the exwiment. Alter heart rate and arterial 
pressure were reco&d, microspheres were injected for 
initial blood flow measttrements. Dogs were injected with 
lidocaine (2 tog/kg intravenously) just before coronary oc- 
clusian to prevent the occurrence of ventricular fibrillation. 
Lidocaine was administered as needed to either group after 
reporfusion. The I& circumfiex coronary artery was then 
occluded for90min by a saareoccluder. Although coronary 
flow was not directly measured in the artery. the entire 
artery was pulled into the snare and clamped into place for 
the duration of the occlusion. After 45 min of occlusion, a 
second injection of microspheres was made. After 90 min of 
occlusion. the occluder was abruptly released from the 
circumflex artery. Fifteen minutes after repefiusion. the 
third injection ofmicrospheres was given. Additional micw 
spheres were it&ted I iS0 and 360 mitt after rewhtsion. 
&ttodynamic ~wiables and an electrocardiogram were 
continuously monitored throughout the study and recorded 
every 30 min. Body temperature was maintained al 37% 
and ventilation was titrated to maintain arterial blwd gases 
within physiologic range. Dogs with ventricular fibrillation 
that could not be converted into a hemodynamically stable 
rhythm within I min were excluded from the analysis of 
Fatty ackl attaiyais. Blood ~8s collected into sodium 
citrale and platelet-rich plasma. Butylated hydroxytoluene 
(p.S%) was added to prevent unsaturated fatty acid auroxi- 
dation in all samples. The platelet-rich plasma was washed 
thaw times with tris-buffered saline solution (0.05 mobliter 
tris-O.IS moYliter sodium chloride. pH 7.0) and platelets 
TaUe 1. Platelet Fatty Acid Levels in Fish Oil-Fed and Control Dogs 
15.35 ? 2.2 17.87 f 4.39 IO.7 + 2.76 14.74 f 2.78 12.82 + 3.94 0.8 f 0.26 7.71 f 2.46 
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regional myocardial blood flow and infarct size. Three dogs 
from tbe fish oil group and four dogs from control group were 
excluded from the analysis of hemodynamics, regional myo- 
cardial blood flow and myocardial infarct size because these 
animals had ventricular fibrillation that could not immedi- 
ately be converted toa bemudynamically stable rhythm. The 
remaining seven experimental and eight control dogs were 
used for the analysis of infarct size, myocardial blood Row 
and hemudynamics. 
Regional blood llow and Infarct size detsnnhution. To 
determine regional myocardial blood flow, radioactive- 
labeled microspheres (14.5 ? 0.5; I5 &) were used (3M Co., 
New England Nuclear) by methods that have been previ- 
ously described (26). The equation used 10 calculate blood 
flow was: MBF = (CtKW) X (RBWKb), where MBF = 
myocardial blood flow in mUmin per g, Ct = tissue radio- 
activity in countslmin. TW = tissue sample weight in g. 
RBW = reference blood whhdrawal rate in mUmin and Cb = 
total radioactivity in the reference blood sample. To assess 
niyocardial damape. the heart was excised and olaced on a 
perfusion apparaius. The method for dual p&fusion was 
similar IO that previously employed by Lange et al. (27) and 
modified for use in our laboratory (25,28). The heart was 
stained with 1% Iriphenyltetrazolium chloride in phosphate 
buffer (pH 8.5) solution IO reveal the normal tissue (stained 
in red1 and necrotic myocardium (triphenyltetrazolium chlo- 
ride negative) as previously described (25). The area at risk 
and ihe infarct size were calculated as a percent of lotal area 
for Ibe surface of each slice. The aoical surface area and 
basal surface area at risk or infarcied was averaged and 
multiplied by the weight of the myocardial rings to approx- 
imate tissue weight af risk or infarct weight, or b&h. In 
the apical and basal slices, only the basal and apical 
surfaces, respectively. were used for the calculation of 
the weight of infarcted tissue or tissue at risk. With these 
measurements and the individual weights of the myocardial 
rings, the following data were derived: anaat risk as percent 
of left ventricular weight, infarct weight as percent of IefI 
ventricular weighr and infarct size as percent of the area at 
risk. 
Functional changes in platelets were analyzed by platetet 
aggregation studies before and after supplemenaIion. The 
fish oil group showed a significant decrease in the aggrega- 
lion responses to ADP and collagen. Adeaosine diphosphak 
.ggregaliou response was 0.0 f 1.7% before feeding com- 
pared with 37.5 + 1.3% afler feeding (p < 0.05) and collagen 
agBregation response was 55.9 f 2.6% compared with 35.2 = 
1.5% (p < 0.05). The control group did not show any change 
in aggregation response. 
InfareI s& Myocardial infarct size was significantly 
decreased in the fish oil group compared with the control 
group (t3 t 3% vs. 29 f 7% of the area at risk. p < 0.05) 
(Fig. 0. The amount of myocardium at risk for severe 
ischemia{expressed as percent of lett ventricular mass) from 
the proximal circumtlex coronary artery occlusion was com- 
parable in both the fish od and control groups (41.2% vs. 
39.3%, respectively). 
SIaIisIical anal@. All data are presented as mean value Hcmad~es. There was no difference in hear! rate. 
f SEM. Analysis between the groups was done by using an mean arterial blood pressure or calculated rate-pressure 
unpaired I IwI and, where appropriate, analysis of variance 
for repeated measures over time. 
ReSultS 
PhtekI lifdd anaIyl. Platelets were analyzed for fatty 
acid content IO demonstrate adequate intake of omega-3 
faIatty acids and to determine the pattern of fatty acid com- 
position (Table I). There was no difference in the baseline 
levels of faIly acids in the fish oil and control dogs. How- 
ever, afIer fish oil supplementation, there was a significant 
increase in tht platelc: content of eicosapentaeuoic acid 
(20:s omega-B: 0.9 ? 0.56% before versus 7.1 +- 4.6% afIer 
feeding (p < 0.91). No significant change in ebmsapen- 
laeuoic acid was found in the control group plaIekts. The 
content of other omega-3 falty acids, which included the 
measurement of docosabexaenoic (226 ome&) fatty acid, 
was not separately determined. In the fish oilgroup, the total 
of all oIher faIty acids showed a relative decrease, indicating 
a shift in composition from some of the fatty acids in Ihis 
group to cicosapenraenoic acid. The content of amchidunic 
acid (20:4 omega-61 did not change siguilicamly in eiIber 
group (Table I). 
Fiire I. Myowdial infarcl size as asrerrcd by rripbenyllew*_ 
zolium chloride staining in fish oil-fed and control dogs. lexdts ore 
werented as the proponion (%I of the myoardium ot rirk foood to 
be infarcted. 
pmduct at the time points measured between the fish oil and 
controlgroups. There war no difference in the severity of the 
reperfusion arrhythmias between the two groups. 
Blood Row. Regional myowdial blood Row was com- 
pared between the two groups at baseline study, during 
coronary occlusion and three limes during reperfusion (at is. 
150 and 360 min). Al each lime uoint, blwd flow was 
analyzed as transmual. epicardial, midwal! and endocardial. 
To compare the severity of iscbemia during complete coro- 
nary occlusion in the two groups. we analyzed the amount of 
myowdium that had defined reductions in blood Row (Fig. 
F&are 1. Cooqmison of the severity of ischemia within the myo- 
cudiom at risk (AM+) between fish o&fed and control dogs. 
Radiolabeled microspheres were injected oiler 45 min of complete 
eomnary wclusion. We analyzed the amount of myocardium fpre- 
rented BS percent oftheareaat risk) that showed ad&cd reduction 
in regional myoardial blood ilow (perrent of baseline regional 
myowdial bkxd Row) during complete coronary occlusion. There 
was nostatistically significant dilTereocc between the fish oil and the 
comrol gmops with respect to the amount of myocxdiom having 
<So%. <X% and 40% olbseline myocordird blood Row during 
comnory occlusion. 
Fiturr 3. Regional myocardiot blmd flow (epicardial and codoar- 
dial) wthin the area at risk in fish oi!-fed and control dogs. 
Badiolabeled muossheres were inimed and serial analvsis was 
performed at baseline (PRE,. at iS rain of corooary &clurioo 
@CCL) and at IS. IS0 and 360 min afkr teperfosion. The data 
presented an: obtained from analysis of myowdium tbot bad <X9% 
of myocxdiol blood Row during EOIURBP/ oaIwioo. (The amoat of 
tissue with that anwont ot ischemia was comparable in the two 
groups [Fig. ?I.) The control group demonstrated significantly more 
rndocardiol blood Row than did the fish oil group at IS min after 
repcrfusion. 
2). There was DO significant diiTerence between the two 
groups in the quantity of myoardium (determined ns a 
percent of the area at risk) that had a5G%. ~30% and 5 10% 
of baseline myocardial blood flow doting coronary occlu- 
sion. When endow&al and epicardial blood flow were 
compared at baseline study (before occlusion) and during 
occlusion, there was no diierence between the fish oil and 
control groups (Fig. 3). However, at IS min after reperfu- 
sion, endowdial hyperemia was greater in the control group 
than in the fish oil group (p < 0.0% but there WBS no 
ditierence in the epicardial ayer (Fig. 3). At IS0 and 364l min 
after reperfusion. there WOE no difference in epicardial and 
endocardial blood flow between the two groups (Fig. 3). 
The rcsulls of this study demonstrate that dietary supple- 
mentation with fish oil reduces myocardial necrosis at?er 
90 min of coronary occlusion followed by 6 h of repelfusion 
in an open chest canine model. Culp et al. (20) previously 
demonstrated that dietary fish oil supplementation for 4 10 6 
weeks resulted in smaller infarcts after 24 h of comnary 
artery occlusion in preinstromented conscious dogs. Hock et 
al. (21) also reported that after 4 weeks of fish oil supple- 
mentation, anesthetized ra!s had a significant reduction in 
the loss of crestine kinase after 6 h of pemmnent coronary 
ligation. 
J3tTec~~ of omega.3 Cnny seids. The mechanisms by which 
fish oil supplementation mediates protective effects against 
IS min of repcrfuaion, where we found an increased hyper- 
emit response within the endocsrdium in the control group. 
The finding of more endocardial hygcremia early after repcr- 
fusion in the control group is in contrast o the observation of 
Hartog et rd. (44). in a model of open chest anesthetized 
pigs, they observed that fish oil supplementation increased 
the hypercmic response during report&ion after 15 min of 
coronary occlusion. These conflicting data may be attributed 
to differences in experimental design (that is, dissimilsr 
ischemic time) or may bc related to variations between 
animal species. Whether the endocardial hypcrcmia at 
15 min produced additional “repcrfusion injury” in the 
control dogs and therefore relative myocardial protection in 
the fish oil group can be speculated. 
Hemodynamtcs. In this study, we also found no signiti- 
cant diiercnoc between groups in heart rate, blood pressure 
or rate-prcssun product. Thus, the dissimilarity in infarct 
size between the groups cannot bc explained by variation in 
o~vncn demand hctwecn the arouos. Withwt a clear diier- 
en& in ischemic time or oxygen demand to explain the 
dissimilarltv in infarct size. an alternative hvnothesis is 
needed. It is possible that the anti-inflammato~ ~&ece of 
omega-3 fatty acids arc important. Inhibition of ncutmphil 
infiltration into scverely iscbcmic myaardium has been 
shown to rcduce ntyocardial infsrct size (45-47). Thus, by 
inhibiting prostaglandin and leukotricnc formation, decreas- 
ing platelet-activating factor prodnotion (48). reducing cyto. 
kine formation (5) and decnasing free oxygen radical forma- 
tion by neutmphils (49). omega-3 fatIy acids may decrease 
chemotaxis and favorably mcdify the inilammatory reaction 
in the mycwdium after ischemia with or without repettik 
sion. 
myocardiai necrosis induced by ischemia. whether or not it 
is followed by rcperfusion, are currently incompletely un- 
derstood. However. omeaa-3 fattv acids. which are found in 
high quantities in marine oils, have a’varicty of biologic 
effects that may al&t the diverse pathophysiologic pro- 
cesses operating during myocardial ischemia and reperfu- 
sion. 
Robably the best described effect of omega-3 fatty acids 
is thei; tnodiiication of eicosanoid metabolism. Ir.corpra- 
tion of eicasapentaenoic acid (20~5 omega-3) into cell mem- 
brane phaspholipids causes competitive inhibition of cy- 
ciooxygenase and decreases the conversion of arachidonic 
acid (20:4 omega-61 to prostaglandins (1229). Similarly, 
eicosapentaenoic acid also inhibits the formation of leuko- 
trienes by lipoxygcnascs (13-U). Simultaneously, eicosap 
enraenoic acid acts as a substrate for thesa enzymes and is 
metabolized to triene prostaglandins and modified leuko- 
tricnes, rnsny of which have significantly less biologic activ- 
ity than their omega.6 derivatives (29-31). 
Studies that have focused on the effect of cyclooxygenase 
inhibitors on infarct size in animal models have failed to 
show any consistent benefits (32-341, with the exception of 
ibuprofen (35.36). However specific thromboxane A2 syn- 
theta% inhibitors (37) and receptor blockers (38,39) have 
been shown to reduce infarct size in dogs, suggesting an 
impartant role of ihromboxane As in the pathophysiology of 
myocardial irchemia. Studies t4D) utilizing BW 7SSC. an 
inhibitor of both cyclooxygcnase and lipoxygenase, have 
also shown reduction in canine infarct size, indicating the 
significance of lipoxygenase products. Other studies have 
shown a reduction in infarct size in models of ischemia and 
rcpcrfusion after the use of a peptidoleukotriene antagonist 
(41) and specific lipoxygenase inhibitors (42). 
Eicosapentaenoic acid affects both cyclooxygcnase and 
lipoxygenase activity and causes a significant decrease in 
thromhoxane A, and leukotriene production. Therefore, it 
can be urouosed that at least Dart of the beneficial effects of 
fish oil supplementation on infarct size is mediated throunh 
its modification of the eicosanoid metabolism. 
Myncardill blood fluw. Other studies indicate that fish oil 
supplementation may increase the wlease of endothelium- 
derived rclnxing factor (43) and this effect would favor 
coronary vasodilation and increase blood flow ss well as 
inhibit platelet aggregation. However. despite finding antiag- 
gregatory effects on olatelets (confirmina the bioloaic effect 
of the feeding protocol), we found no favorable elects on 
regional myocatdial blood Row during coronary occlusion in 
the fish oil group compared wiih the control group. Therc- 
fore. the difference in infarct size abscrvcd in this study 
cannot be explained by the ditfercnce in ischcmic insult 
between the groups. 
We had also proposed that myocardial blood flow after 
reperfusion might improve by promoting coronary vnsodila- 
tion and inhibiting platelet and neutrophil aggregation. How- 
ever, there was no significant difference in regional myocar. 
dial blood flow during the reperfusion period except at 
Coaclwb~. Our study demonstrates that omega-3 fatty 
acid supplementation can reduce myocardtal ncc&is in a 
canine model of ischemic injury and reperfusion. We did not 
find convincing evidence that the protective e&cc of omc 
ga-3 fatty acids was due to preserved myocardial regional 
blood flow or alteration in hemodvnamic reswnses to isch- 
emia. Further investigation is needed IO betermine the 
proteclive mechani .ins of omega-3 fatty acids ~1 myocardiil 
infarct size. 
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